Found 162 matching trials
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) PHASE1 Patients enrolled on this study will have received a stem cell transplant. ...
Show More Location
Texas Childrens Hospital
Learn More & Join Trial
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants PHASE2 The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Show More Location
RDSS Research Center
Learn More & Join Trial
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus N/A 296 million people worldwide are infected with the hepatitis B virus (HBV),...
Show More Location
Hôpital Saint Louis AP-HP
Learn More & Join Trial
Administration of Virus-Specific Cytotoxic T-Lymphocytes PHASE1 The main purpose of this study is to see if these T-lymphocytes are safe. T...
Show More Location
National Institute of Health (NIH)
Learn More & Join Trial
Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) NA Single-patient trial aiming to provide immunological consolidation followin...
Show More Learn More & Join Trial
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation PHASE1 This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Show More Status
Active Not Recruiting
Location
Childrens National Medical Center
Learn More & Join Trial
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases PHASE1 Patients have a type of a lymph node cancer called lymphoma, a tumor of the...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) PHASE1 BK cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodig...
Show More Location
University of California San Francisco
Learn More & Join Trial
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies PHASE2 This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT PHASE1 Subjects are having a bone marrow or SCT for either a type of cancer of the...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial